chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased, Pain in extremity, Paraesthesia, Pruritus
Clinical narrative: tingling; Itchy; arm was sore; Fast heart rate; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), PAIN IN EXTREMITY (arm was sore), HEART RATE INCREASED (Fast heart rate), PARAESTHESIA (tingling) and PRURITUS (Itchy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DIZZINESS (dizzy). On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore) and HEART RATE INCREASED (Fast heart rate). On 06-Feb-2021, the patient experienced PARAESTHESIA (tingling) and PRURITUS (Itchy). On 02-Feb-2021, DIZZINESS (dizzy) had resolved. On 04-Feb-2021, PAIN IN EXTREMITY (arm was sore) and HEART RATE INCREASED (Fast heart rate) had resolved. At the time of the report, PARAESTHESIA (tingling) and PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug was not reported. Treatment for the event was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site reaction
Clinical narrative: Delayed hypersensitivity reaction exclusive to moderna vaccine; Red patch on arm; Rash on arm that covered part of bicep; Covid arm; A very slight itch where the injection was given; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE HYPERSENSITIVITY (Delayed hypersensitivity reaction exclusive to moderna vaccine), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (A very slight itch where the injection was given), VACCINATION SITE ERYTHEMA (Red patch on arm) and VACCINATION SITE RASH (Rash on arm that covered part of bicep) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE REACTION (Covid arm). 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (A very slight itch where the injection was given). On 24-Jan-2021, the patient experienced VACCINATION SITE HYPERSENSITIVITY (Delayed hypersensitivity reaction exclusive to moderna vaccine). 24-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red patch on arm) and VACCINATION SITE RASH (Rash on arm that covered part of bicep). On 27-Jan-2021, VACCINATION SITE HYPERSENSITIVITY (Delayed hypersensitivity reaction exclusive to moderna vaccine), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE ERYTHEMA (Red patch on arm) and VACCINATION SITE RASH (Rash on arm that covered part of bicep) had resolved. At the time of the report, VACCINATION SITE PRURITUS (A very slight itch where the injection was given) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: On 21-JAN-2021 new event (very slight itch) was added. Onset date of the event (covid arm) changed (from 24-JAN-2021 to 21-JAN-2021).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Hyperhidrosis, Peripheral swelling, Vaccination site movement impairment
Clinical narrative: Sweat during sleep; swollen; Difficulty in bending fingers; Pain in the back; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Pain in the back), HYPERHIDROSIS (Sweat during sleep), PERIPHERAL SWELLING (swollen) and VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty in bending fingers) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 029L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included EPLERENONE, BROMELAINS;TRYPSIN, ALLOPURINOL, MULTIVITAMIN & MINERAL, MACROGOL 3350 (MIRALAX), ASCORBIC ACID, BETACAROTENE, COPPER, NICOTINAMIDE, SELENIUM, TOCOPHEROL, XANTOFYL, ZINC (LUTEIN +) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced BACK PAIN (Pain in the back), PERIPHERAL SWELLING (swollen) and VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty in bending fingers). On 08-Feb-2021, the patient experienced HYPERHIDROSIS (Sweat during sleep). At the time of the report, BACK PAIN (Pain in the back), HYPERHIDROSIS (Sweat during sleep), PERIPHERAL SWELLING (swollen) and VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty in bending fingers) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Lip swelling, Paraesthesia oral, Taste disorder
Clinical narrative: Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips; Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips; Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lip; Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lips; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), PARAESTHESIA ORAL (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), HYPOAESTHESIA ORAL (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lip) and LIP SWELLING (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lips) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No medical history information were provided.  Concomitant products included ESOMEPRAZOLE, AMITRIPTYLINE and CROMOGLICATE SODIUM (CROMOLYN [CROMOGLICATE SODIUM]) for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced TASTE DISORDER (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), PARAESTHESIA ORAL (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), HYPOAESTHESIA ORAL (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lip) and LIP SWELLING (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lips). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, TASTE DISORDER (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), PARAESTHESIA ORAL (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), HYPOAESTHESIA ORAL (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lip) and LIP SWELLING (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 12_may-2021 contains non-significant information.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Nausea
Clinical narrative: rash at the injection site; itchy at the injection site; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash at the injection site), INJECTION SITE PRURITUS (itchy at the injection site) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included RIVAROXABAN (XARELTO), FUROSEMIDE, METFORMIN, LISINOPRIL and THYROID (ARMOUR THYROID) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE RASH (rash at the injection site), INJECTION SITE PRURITUS (itchy at the injection site) and NAUSEA (Nausea). At the time of the report, INJECTION SITE RASH (rash at the injection site), INJECTION SITE PRURITUS (itchy at the injection site) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient used dalcaecarm 240mg for unknown reasons.  Patient applied Something warm on arm  for the symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: No new information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history.  The patient's past medical history included Hypertension since an unknown date and Hypothyroidism since an unknown date. Concomitant products included POTASSIUM and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-056895 (Patient Link).   Reporter did not allow further contact
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site reaction, Vaccination site erythema
Clinical narrative: Round patch at injection site; Pinkish at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (Round patch at injection site) and VACCINATION SITE ERYTHEMA (Pinkish at injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE REACTION (Round patch at injection site) and VACCINATION SITE ERYTHEMA (Pinkish at injection site). At the time of the report, INJECTION SITE REACTION (Round patch at injection site) and VACCINATION SITE ERYTHEMA (Pinkish at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Muscle spasms, Product administered at inappropriate site, Vaccination site pain
Clinical narrative: Left knee swelled up; Cramping in back of left leg up to buttocks; Left leg tender and achy; Vaccine given in left knee muscle; A spontaneous report was received from a consumer concerning an 83-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) inappropriately in left leg by the knee, left knee swelled up, cramping in back of left leg up to buttocks and left leg was tender and achy.  The patients medical history,as provided by the reporter, included lymphedema in both her arms and can't take vaccines in either arm.  No relevant concomitant medications were reported.   On 28 Jan 2021, prior to the onset of events, the patient received their first of two planned dose of mRNA-1273 (Lot number: 012M20A) vaccine intramuscularly in the left leg by the knee for prophylaxis of COVID-19 infection.  On an unknown date, patient experienced knee swelling and cramping in back of left leg up to the buttocks along with tenderness and achiness in the leg.  No Treatment information for the event was provided.  Action taken mRNA-1273 in response to the event was not reported.  The outcome of the events, left knee swelled up, cramping in back of left leg up to buttocks and left leg tender and achy was unknown.  The outcome of the event vaccine administered at inappropriate site was considered resolved.; Reporter's Comments: This report refers to a case of vaccine administered at inappropriate site for mRNA-1273 (lot # 012M20A) with AE reported of joint swelling, muscle spasms and vaccination site pain.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye swelling, Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Hives; Swollen Eyes; Chills; tchy Sensation - Near Injection Site; Swelling - Near Injection Site; Redness - Near Injection Site; Rash - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), EYE SWELLING (Swollen Eyes), INJECTION SITE PRURITUS (tchy Sensation - Near Injection Site), INJECTION SITE SWELLING (Swelling - Near Injection Site) and INJECTION SITE ERYTHEMA (Redness - Near Injection Site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced INJECTION SITE PRURITUS (tchy Sensation - Near Injection Site), INJECTION SITE SWELLING (Swelling - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site). On 22-Feb-2021, the patient experienced URTICARIA (Hives), EYE SWELLING (Swollen Eyes) and CHILLS (Chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 16-Feb-2021, INJECTION SITE PRURITUS (tchy Sensation - Near Injection Site), INJECTION SITE SWELLING (Swelling - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site) had resolved. At the time of the report, URTICARIA (Hives), EYE SWELLING (Swollen Eyes) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Urticaria
Clinical narrative: Hives; Swollen Eyes; Chills; tchy Sensation - Near Injection Site; Swelling - Near Injection Site; Redness - Near Injection Site; Rash - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), EYE SWELLING (Swollen Eyes), INJECTION SITE PRURITUS (tchy Sensation - Near Injection Site), INJECTION SITE SWELLING (Swelling - Near Injection Site) and INJECTION SITE ERYTHEMA (Redness - Near Injection Site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced INJECTION SITE PRURITUS (tchy Sensation - Near Injection Site), INJECTION SITE SWELLING (Swelling - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site). On 22-Feb-2021, the patient experienced URTICARIA (Hives), EYE SWELLING (Swollen Eyes) and CHILLS (Chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 16-Feb-2021, INJECTION SITE PRURITUS (tchy Sensation - Near Injection Site), INJECTION SITE SWELLING (Swelling - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site) had resolved. At the time of the report, URTICARIA (Hives), EYE SWELLING (Swollen Eyes) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on her chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on her chest) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced RASH (rash on her chest). On 07-Feb-2021, RASH (rash on her chest) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Gotten worse today; Redness that had expended about 4 inches around the injection site; Itchy; Tenderness; Hard around; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Hard around), CONDITION AGGRAVATED (Gotten worse today), VACCINATION SITE ERYTHEMA (Redness that had expended about 4 inches around the injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE PAIN (Tenderness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE MASS (Hard around), VACCINATION SITE ERYTHEMA (Redness that had expended about 4 inches around the injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE PAIN (Tenderness). On 05-Feb-2021, the patient experienced CONDITION AGGRAVATED (Gotten worse today). At the time of the report, VACCINATION SITE MASS (Hard around), CONDITION AGGRAVATED (Gotten worse today), VACCINATION SITE ERYTHEMA (Redness that had expended about 4 inches around the injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE PAIN (Tenderness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site dysaesthesia, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: felt sensitivity in her arm as if she first got the shot; warm to the touch; tender; upraised irregular bordered red spot in the area where the vaccine was injected.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DYSAESTHESIA (felt sensitivity in her arm as if she first got the shot), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (upraised irregular bordered red spot in the area where the vaccine was injected.) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE DYSAESTHESIA (felt sensitivity in her arm as if she first got the shot), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (upraised irregular bordered red spot in the area where the vaccine was injected.). At the time of the report, VACCINATION SITE DYSAESTHESIA (felt sensitivity in her arm as if she first got the shot), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (upraised irregular bordered red spot in the area where the vaccine was injected.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site warmth, Pain in extremity, Swelling, Tenderness
Clinical narrative: Red spot; Swollen; Tenderness; Warm; Soreness in her arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Red spot), SWELLING (Swollen), TENDERNESS (Tenderness), INJECTION SITE WARMTH (Warm) and PAIN IN EXTREMITY (Soreness in her arm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M201A and 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Bacitracin, Neosporin). Concomitant products included METRONIDAZOLE for Rosacea, CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID), HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) and OMEPRAZOLE for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 21-Feb-2021, the patient experienced ERYTHEMA (Red spot), SWELLING (Swollen), TENDERNESS (Tenderness), INJECTION SITE WARMTH (Warm) and PAIN IN EXTREMITY (Soreness in her arm). On 27-Feb-2021, ERYTHEMA (Red spot), SWELLING (Swollen), TENDERNESS (Tenderness), INJECTION SITE WARMTH (Warm) and PAIN IN EXTREMITY (Soreness in her arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Reporter information was updated. Product Dose details was updated. Patient details are updated (height, weight, pregnancy status). Added relevant history like allergic to Bacitracin, Neosporin.Events are recovered.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain, Pyrexia
Clinical narrative: Fatigue; Achy; Nausea; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), NAUSEA (Nausea), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (Achy), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (Fever). On 25-Feb-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, PAIN (Achy), PYREXIA (Fever) and FATIGUE (Fatigue) had not resolved and NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination complication
Clinical narrative: his tick started after vaccination; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (his tick started after vaccination) and HEADACHE (headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Cholesterol and Diabetes.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION COMPLICATION (his tick started after vaccination) and HEADACHE (headache). At the time of the report, VACCINATION COMPLICATION (his tick started after vaccination) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Cholesterol medicine, Medication for diabetes and Blood pressure medicine.  No treatment information was provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Gait inability, Joint swelling, Pain
Clinical narrative: Swollen ankle; Could not walk; Excruciating pain; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swollen ankle), GAIT INABILITY (Could not walk) and PAIN (Excruciating pain) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder, Drug allergy (Biaxin, morphine, codeine), Ovarian cancer since October 2018 and Dyspepsia. Concomitant products included IBEROGAST for Dyspepsia, PROBIOTICS NOS for Probiotic therapy, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder, VITAMIN D3, MAGNESIUM CITRATE and PLANTAGO OVATA SEED HUSK (PSYLLIUM HUSKS) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced JOINT SWELLING (Swollen ankle), GAIT INABILITY (Could not walk) and PAIN (Excruciating pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, JOINT SWELLING (Swollen ankle), GAIT INABILITY (Could not walk) and PAIN (Excruciating pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.   This case was linked to MOD-2021-053345 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow-up contains non-significant information. On 04-May-2021: Follow-up contains additional information: Updated patient demographic details, medical history, concomitant medication On 24-Jun-2021: Follow-up contains Non-significant information.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pyrexia, Vomiting
Clinical narrative: throwing up; fever; tenderness on their arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (tenderness on their arm), VOMITING (throwing up) and PYREXIA (fever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE PAIN (tenderness on their arm). On 25-Feb-2021, the patient experienced VOMITING (throwing up) and PYREXIA (fever). At the time of the report, INJECTION SITE PAIN (tenderness on their arm), VOMITING (throwing up) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Headache, Hypoaesthesia, Oropharyngeal discomfort
Clinical narrative: throat closed up; tongue got big; she became numb on her right side; her vision went blurry; having a hard time breathing; throat got a weird feeling; chest pain; her vision goes in and out which she thinks is from the headache; headache; A spontaneous report was received from a consumer concerning a 61-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced throat closed up, tongue got big, became numb on right side, vision went blurry, hard time breathing, throat got a weird feeling and started to close, chest pain, vision goes in and out when she thinks of the headache, and headache.  The patient's medical history as reported by the reporter included food allergy especially to strawberries, Medication allergies to flu shots, sulfa, phenegran, prednisone, Diabetes mellitus in 2017, Breast Cancer in 2017. Concomitant medication was not reported.  On 15 Jan at 4:45 pm 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) through an unknown route at right upper arm for prophylaxis of COVID-19 infection.  On 15 Jan 2021, 5 min after receiving the vaccine, her throat closed up, tongue got big, became numb on right side, vision went blurry, hard time breathing, throat got a wired feeling and started to close.  Within 30 min she was taken to emergency room. And after that  she also had  chest pain, hard time breathing, headache and her vision goes in out when she thinks of headache.  She was advised to get admitted in hospital, but she declined. She was still out of work. Patient had similar events when she took flu shots twenty years ago.  Treatment activities for event was unknown.  Action taken with mRNA-1273 in response to the events was reported as unknown.   The outcome of events, throat closed up, tongue got big, became numb on right side, vision went blurry, hard time breathing, throat got a wired feeling and started to close ,  chest pain, hard time breathing, headache and her vision goes in out when she thinks of headache was reported as recovering/resolving.; Reporter's Comments: This case concerns a 61-year-old female who experienced NS unexpected events of chest pain, dyspnea, throat tightness, swollen tongue, oropharyngeal discomfort, hypoesthesia, vision blurred, visual impairment, and NS expected headache.  The events occurred 5 minutes after the first dose of mRNA-1273. Events resolving. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue, Throat tightness, Vision blurred, Visual impairment
Clinical narrative: throat closed up; tongue got big; she became numb on her right side; her vision went blurry; having a hard time breathing; throat got a weird feeling; chest pain; her vision goes in and out which she thinks is from the headache; headache; A spontaneous report was received from a consumer concerning a 61-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced throat closed up, tongue got big, became numb on right side, vision went blurry, hard time breathing, throat got a weird feeling and started to close, chest pain, vision goes in and out when she thinks of the headache, and headache.  The patient's medical history as reported by the reporter included food allergy especially to strawberries, Medication allergies to flu shots, sulfa, phenegran, prednisone, Diabetes mellitus in 2017, Breast Cancer in 2017. Concomitant medication was not reported.  On 15 Jan at 4:45 pm 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) through an unknown route at right upper arm for prophylaxis of COVID-19 infection.  On 15 Jan 2021, 5 min after receiving the vaccine, her throat closed up, tongue got big, became numb on right side, vision went blurry, hard time breathing, throat got a wired feeling and started to close.  Within 30 min she was taken to emergency room. And after that  she also had  chest pain, hard time breathing, headache and her vision goes in out when she thinks of headache.  She was advised to get admitted in hospital, but she declined. She was still out of work. Patient had similar events when she took flu shots twenty years ago.  Treatment activities for event was unknown.  Action taken with mRNA-1273 in response to the events was reported as unknown.   The outcome of events, throat closed up, tongue got big, became numb on right side, vision went blurry, hard time breathing, throat got a wired feeling and started to close ,  chest pain, hard time breathing, headache and her vision goes in out when she thinks of headache was reported as recovering/resolving.; Reporter's Comments: This case concerns a 61-year-old female who experienced NS unexpected events of chest pain, dyspnea, throat tightness, swollen tongue, oropharyngeal discomfort, hypoesthesia, vision blurred, visual impairment, and NS expected headache.  The events occurred 5 minutes after the first dose of mRNA-1273. Events resolving. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Big swollen lymph node under her armpit of injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Big swollen lymph node under her armpit of injection site) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 26-Jan-2021, the patient experienced LYMPHADENOPATHY (Big swollen lymph node under her armpit of injection site). At the time of the report, LYMPHADENOPATHY (Big swollen lymph node under her armpit of injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dizziness, Headache, Myalgia
Clinical narrative: diziness; aches and pains; vomitting; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (diziness), MYALGIA (aches and pains), VOMITING (vomitting), CHILLS (chills) and PYREXIA (fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced DIZZINESS (diziness), MYALGIA (aches and pains), VOMITING (vomitting), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). The patient was treated with PHENIRAMINE at an unspecified dose and frequency. On 01-Feb-2021, DIZZINESS (diziness), MYALGIA (aches and pains), VOMITING (vomitting), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, COVID-19: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: diziness; aches and pains; vomitting; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (diziness), MYALGIA (aches and pains), VOMITING (vomitting), CHILLS (chills) and PYREXIA (fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced DIZZINESS (diziness), MYALGIA (aches and pains), VOMITING (vomitting), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). The patient was treated with PHENIRAMINE at an unspecified dose and frequency. On 01-Feb-2021, DIZZINESS (diziness), MYALGIA (aches and pains), VOMITING (vomitting), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, COVID-19: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative, Therapy non-responder
Clinical narrative: negative for antibodies ~3 weeks after she got the vaccine; Therapy non-responder; A spontaneous report was received from a Healthcare Professional concerning a 22-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events negative for antibodies ~3 weeks after she got the vaccine.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.   on unknown date the patient experienced event negative for antibodies ~3 weeks after she got the vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, negative for antibodies ~3 weeks after she got the vaccine and therapy non- responder was not reported.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Vaccination site bruising, Vaccination site pruritus
Clinical narrative: itchiness at the injection site; Bruise appearance spot at injection site; black, blue and red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the injection site), VACCINATION SITE BRUISING (Bruise appearance spot at injection site) and SKIN DISCOLOURATION (black, blue and red) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the injection site), VACCINATION SITE BRUISING (Bruise appearance spot at injection site) and SKIN DISCOLOURATION (black, blue and red). At the time of the report, VACCINATION SITE PRURITUS (itchiness at the injection site) and VACCINATION SITE BRUISING (Bruise appearance spot at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment details included not provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: redness at the injection site; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE PRURITUS (itching at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE PRURITUS (itching at the injection site). At the time of the report, INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE PRURITUS (itching at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Vaccination site warmth
Clinical narrative: hot; itchy; quarter size rash; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), PRURITUS (itchy), RASH (quarter size rash) and ERYTHEMA (red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot), PRURITUS (itchy), RASH (quarter size rash) and ERYTHEMA (red). At the time of the report, VACCINATION SITE WARMTH (hot), PRURITUS (itchy), RASH (quarter size rash) and ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Vaccination site pain, Vomiting
Clinical narrative: left arm is sore; headache; nausea; Threw up once; tired; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VOMITING (Threw up once), FATIGUE (tired), VACCINATION SITE PAIN (left arm is sore) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced NAUSEA (nausea), VOMITING (Threw up once) and FATIGUE (tired). On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (left arm is sore) and HEADACHE (headache). On 04-Feb-2021, VOMITING (Threw up once) had resolved. At the time of the report, NAUSEA (nausea), FATIGUE (tired), VACCINATION SITE PAIN (left arm is sore) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hot flush, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: prickly sensation all over body; hot flash; kind of hot near injection site; red at injection site; itches near injection site; swollen arm below injection site; painful to touch at injection site; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (prickly sensation all over body), HOT FLUSH (hot flash), INJECTION SITE WARMTH (kind of hot near injection site), INJECTION SITE ERYTHEMA (red at injection site) and INJECTION SITE PRURITUS (itches near injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ATENOLOL and LOSARTAN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PARAESTHESIA (prickly sensation all over body), HOT FLUSH (hot flash), INJECTION SITE WARMTH (kind of hot near injection site), INJECTION SITE ERYTHEMA (red at injection site), INJECTION SITE PRURITUS (itches near injection site), INJECTION SITE SWELLING (swollen arm below injection site), INJECTION SITE PAIN (painful to touch at injection site) and ARTHRALGIA (joint pain). At the time of the report, PARAESTHESIA (prickly sensation all over body), HOT FLUSH (hot flash), INJECTION SITE WARMTH (kind of hot near injection site), INJECTION SITE ERYTHEMA (red at injection site), INJECTION SITE PRURITUS (itches near injection site), INJECTION SITE SWELLING (swollen arm below injection site), INJECTION SITE PAIN (painful to touch at injection site) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Paraesthesia
Clinical narrative: prickly sensation all over body; hot flash; kind of hot near injection site; red at injection site; itches near injection site; swollen arm below injection site; painful to touch at injection site; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (prickly sensation all over body), HOT FLUSH (hot flash), INJECTION SITE WARMTH (kind of hot near injection site), INJECTION SITE ERYTHEMA (red at injection site) and INJECTION SITE PRURITUS (itches near injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ATENOLOL and LOSARTAN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PARAESTHESIA (prickly sensation all over body), HOT FLUSH (hot flash), INJECTION SITE WARMTH (kind of hot near injection site), INJECTION SITE ERYTHEMA (red at injection site), INJECTION SITE PRURITUS (itches near injection site), INJECTION SITE SWELLING (swollen arm below injection site), INJECTION SITE PAIN (painful to touch at injection site) and ARTHRALGIA (joint pain). At the time of the report, PARAESTHESIA (prickly sensation all over body), HOT FLUSH (hot flash), INJECTION SITE WARMTH (kind of hot near injection site), INJECTION SITE ERYTHEMA (red at injection site), INJECTION SITE PRURITUS (itches near injection site), INJECTION SITE SWELLING (swollen arm below injection site), INJECTION SITE PAIN (painful to touch at injection site) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.